Page 178 - 南京医科大学学报自然科学版
P. 178
第41卷第7期
·1108 · 南 京 医 科 大 学 学 报 2021年7月
验证结果证实该复合杂合突变为常染色体隐性遗 sequencing and complex disease susceptibility gene dis⁃
传,初步判定为可疑致病,但临床表型与基因型间 covery:study design considerations[J]. J Med Genet,
的相关性仍无法明确。本研究与既往大多ARSB基 2015,52(1):10-16
因突变位点研究相同,均止步于蛋白质三维结构及 [11] 刘 洁,华海应,晁红颖,等. 急性髓系白血病中 DN⁃
MT3A p.R882的共存基因突变分析[J]. 南京医科大学
相关软件致病性预测,缺少进一步功能验证,对临
学报(自然科学版),2020,40(9):1331-1337
床表型与基因型的相关性未能进行确认,基因突变
[12] KIEFER F,ARNOLD K,KÜNZLI M,et al. The SWISS⁃
的研究还需进一步深入,探索基因治疗的可能。但
MODEL repository and associated resources[J]. Nucleic
本研究新发现的复合杂合突变,扩大了 ARSB 的致
Acids Res,2009,37(Database issue):D387-D392
病基因谱,指导患者临床诊治及预后判断,基因诊 [13] BIASINI M,BIENERT S,WATERHOUSE A,et al. SWISS
断在罕见疾病诊治中是不可或缺的手段。 ⁃MODEL:modelling protein tertiary and quaternary struc⁃
[参考文献] ture using evolutionary information[J]. Nucleic Acids
Res,2014,42(W1):W252-W258
[1] TOMANIN R,KARAGEORGOS L,ZANETTI A,et al.
[14] ARNOLD K,BORDOLI L,KOPP J,et al. The SWISS ⁃
Mucopolysaccharidosis type Ⅵ(MPS Ⅵ)and molecular
MODEL workspace:a web⁃based environment for protein
analysis:review and classification of published variants
structure homology modelling[J]. Bioinformatics,2006,
in the ARSB gene[J]. Hum Mutat,2018,39(12):1788-
22(2):195-201
1802
[15] GUEX N,PEITSCH M C,SCHWEDE T. Automated com⁃
[2] GOMES D F,GALLO L G,LEITE B F,et al. Clinical ef⁃
parative protein structure modeling with SWISS⁃MODEL
fectiveness of enzyme replacement therapy with galsul⁃
and Swiss⁃PdbViewer:a historical perspective[J]. Elec⁃
fase in mucopolysaccharidosis type Ⅵ treatment:system⁃
trophoresis,2009,30(Suppl 1):S162-S173
atic review[J]. J Inherit Metab Dis,2019,42(1):66-76
[16] KARAGEORGOS L,HARMATZ P,SIMON J,et al. Muta⁃
[3] AMINZADEH M,MALEKPOUR N,GHANDIL P. Identi⁃
tional analysis of mucopolysaccharidosis type VI patients
fication of arylsulfatase B gene mutations and clinical pre⁃
undergoing a trial of enzyme replacement therapy[J].
sentations of Iranian patients with mucopolysaccharidosis
Hum Mutat,2004,23(3):229-233
Ⅵ[J]. Gene,2019,706:1-5
[17] GIRALDO G A,AYALA⁃RAMÍREZ P,PRIETO J C,et
[4] QUARTEL A,HENDRIKSZ C J,PARINI R,et al. Growth
al. Molecular findings of Colombian patients with type VI
charts for individuals with mucopolysaccharidosis Ⅵ(Ma⁃
mucopolysaccharidosis(Maroteaux ⁃ Lamy syndrome)[J].
roteaux⁃Lamy syndrome)[J]. JIMD Rep,2015,18:1-11
Meta Gene,2016,7:83-89
[5] LACHMAN R S,BURTON B K,CLARKE L A,et al. Mu⁃
copolysaccharidosis IVA(morquio a syndrome)and Ⅵ [18] SAWAMOTO K,CHEN H H,ALMÉCIGA⁃DÍAZ C J,et
al. Gene therapy for mucopolysaccharidoses[J]. Mol Gen⁃
(Maroteaux⁃Lamy syndrome):under⁃recognized and chal⁃
lenging to diagnose[J]. Skeletal Radiol,2014,43(3): et Metab,2018,123(2):59-68
359-369 [19] MATHEW J,JAGADEESH S M,BHAT M,et al. Muta⁃
[6] 张余春,王 昆,马向华. 甲状腺结节术前基因诊断的 tions in ARSB in MPS Ⅵ patients in India[J]. Mol Genet
研究进展[J]. 南京医科大学学报(自然科学版),2018, Metab Rep,2015,4:53-61
38(10):1472-1476 [20] SUAREZ⁃GUERRERO J L,GÓMEZ H P,ARIAS F J,et
[7] LI H,DURBIN R. Fast and accurate long⁃read alignment al. Mucopolysaccharidosis:clinical features,diagnosis
with Burrows ⁃ Wheeler transform[J]. Bioinformatics, and management[J]. Rev Chil Pediatr,2016,87(4):
2010,26(5):589-595 295-304
[8] MCKENNA A,HANNA M,BANKS E,et al. The genome [21] LIN W D,KE Y Y,CHOU I C,et al. Deletion of exon 4 in
analysis toolkit:a MapReduce framework for analyzing the N⁃acetylgalactosamine⁃4⁃sulfatase gene in a Taiwan⁃
next⁃generation DNA sequencing data[J]. Genome Res, ese patient with mucopolysaccharidosis type Ⅵ[J]. To⁃
2010,20(9):1297-1303 hoku J Exp Med,2015,235(4):267-273
[9] WANG K,LI M,HAKONARSON H. ANNOVAR:func⁃ [22] MALEKPOUR N,VAKILI R,HAMZEHLOIE T. Muta⁃
tional annotation of genetic variants from high⁃throughput tional analysis of ARSB gene in mucopolysaccharidosis
sequencing data[J]. Nucleic Acids Res,2010,38(16): type Ⅵ:identification of three novel mutations in Iranian
e164 patients[J]. Iran J Basic Med Sci,2018,21(9):950-956
[10] WU L,SCHAID D J,SICOTTE H,et al. Case⁃only exome [收稿日期] 2020-02-13